Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Kumar R, Kala P, Narayanan GS, et al. Evaluation and evolution of apparent diffusion coefficient (ADC) in image-guided adaptive brachytherapy (IGABT) for cervical cancer. Brachytherapy. 2021;20(1):112–7.

Article  PubMed  Google Scholar 

Klopp AH. Introduction: Cervical cancer. Semin Radiat Oncol. 2020;30(4):263–4.

Article  PubMed  Google Scholar 

Lemp JM, De Neve JW, Bussmann H, et al. Lifetime prevalence of cervical cancer screening in 55 low- and middle-income countries. JAMA. 2020;324(15):1532–42.

Article  PubMed  PubMed Central  Google Scholar 

Abdel-Wahab M, Grover S, Zubizarreta EH, et al. Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives. Brachytherapy. 2020;19(6):850–6.

Article  PubMed  PubMed Central  Google Scholar 

Malikova H, Burghardtova M, Fejfarova K, et al. Advanced cervical cancer in young women: imaging study of late and very late radiation-related side effects after successful treatment by combined radiotherapy. Quant Imaging Med Surg. 2021;11(1):21–31.

Article  PubMed  PubMed Central  Google Scholar 

Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hung T, Chang HY. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol. 2010;7(5):582–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ko NY, Chen LR, Chen KH. The role of micro RNA and long-non-coding RNA in osteoporosis. Int J Mol Sci. 2020;21(14):4886.

Wang Y, Wang Y, Qin Z, et al. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Expert Opin Drug Metab Toxicol. 2021;17(3):291–306.

Article  CAS  PubMed  Google Scholar 

Qi X, Zhang DH, Wu N, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710–8.

Article  PubMed  Google Scholar 

Conte F, Fiscon G, Sibilio P, et al. An overview of the computational models dealing with the regulatory ceRNA mechanism and ceRNA deregulation in cancer. Methods Mol Biol. 2021;2324:149–64.

Article  CAS  PubMed  Google Scholar 

Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.

Article  PubMed  PubMed Central  Google Scholar 

Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21(1):22–36.

Article  CAS  PubMed  Google Scholar 

Bai X, Wang W, Zhao P, et al. LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression. Carcinogenesis. 2020;41(1):111–21.

Article  PubMed  Google Scholar 

Ji YY, Meng M, Miao Y. lncRNA SNHG1 promotes progression of cervical cancer through miR-195/NEK2 axis. Cancer Manag Res. 2020;12:11423–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui X, Wang X, Zhou X, et al. miR-106a regulates cell proliferation and autophagy by targeting LKB1 in HPV-16-associated cervical cancer. Mol Cancer Res. 2020;18(8):1129–41.

Article  CAS  PubMed  Google Scholar 

Maass PG, Luft FC, Bahring S. Long non-coding RNA in health and disease. J Mol Med (Berl). 2014;92(4):337–46.

Article  CAS  PubMed  Google Scholar 

Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–6.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Q, Wu J, Huang H, et al. lncRNA LIFR-AS1 suppresses invasion and metastasis of non-small cell lung cancer via the miR-942-5p/ZNF471 axis. Cancer Cell Int. 2020;20:180.

Article  PubMed  PubMed Central  Google Scholar 

Xu F, Li H, Hu C. LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer. Biosci Rep. 2019;39(7):BSR20180551.

Wang HF, Lv JQ, Li HH, et al. High long non-coding LIFR-AS1 expression correlates with poor survival in gastric carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(10):5378–84.

PubMed  Google Scholar 

Muller H, Bracken AP, Vernell R, et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 2001;15(3):267–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biswas AK, Johnson DG. Transcriptional and nontranscriptional functions of E2F1 in response to DNA damage. Cancer Res. 2012;72(1):13–7.

Article  CAS  PubMed  Google Scholar 

Berton TR, Mitchell DL, Guo R, et al. Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation. Oncogene. 2005;24(15):2449–60.

Article  CAS  PubMed  Google Scholar 

Engelmann D, Putzer BM. The dark side of E2F1: in transit beyond apoptosis. Cancer Res. 2012;72(3):571–5.

Article  CAS  PubMed  Google Scholar 

Smits VA, Medema RH. Checking out the G(2)/M transition. Biochim Biophys Acta. 2001;1519(1–2):1–12.

CAS  PubMed  Google Scholar 

Suzuki T, Urano T, Miki Y, et al. Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor. Cancer Sci. 2007;98(5):644–51.

Article  CAS  PubMed  Google Scholar 

Jin J, Xu H, Li W, et al. LINC00346 acts as a competing endogenous RNA regulating development of hepatocellular carcinoma via modulating CDK1/CCNB1 axis. Front Bioeng Biotechnol. 2020;8:54.

Article  PubMed  PubMed Central  Google Scholar 

Li S, Liu N, Piao J, et al. CCNB1 expedites the progression of cervical squamous cell carcinoma via the regulation by FOXM1. Onco Targets Ther. 2020;13:12383–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang S, Iyer S, Ran H, et al. Genetically defined, syngeneic organoid platform for developing combination therapies for ovarian cancer. Cancer Discov. 2021;11(2):362–83.

Article  CAS  PubMed  Google Scholar 

Huang X, Shao D, Wu H, et al. Genomic profiling comparison of germline BRCA and non-BRCA carriers reveals CCNE1 amplification as a risk factor for non-BRCA carriers in patients with triple-negative breast cancer. Front Oncol. 2020;10:583314.

Article  PubMed  PubMed Central  Google Scholar 

Konstantinopoulos PA, Ceccaldi R, Shapiro GI, et al. Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer. Cancer Discov. 2015;5(11):1137–54.

Article  CAS  PubMed  PubMed Central  Google Scholar